Highland Capital Management (Tennessee)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.81M | Buy |
54,050
+70
| +0.1% | +$7.52K | 0.31% | 83 |
|
|
2025
Q1 | $5.45M | Sell |
53,980
-730
| -1% | -$73.6K | 0.33% | 80 |
|
|
2024
Q4 | $4.89M | Buy |
+54,710
| New | +$4.89M | 0.28% | 87 |
|
|
2018
Q4 | – | Sell |
-29,739
| Closed | -$1.15M | – | 311 |
|
|
2018
Q3 | $1.15M | Buy |
29,739
+8,561
| +40% | +$330K | 0.08% | 208 |
|
|
2018
Q2 | $693K | Sell |
21,178
-1,093
| -5% | -$35.8K | 0.05% | 248 |
|
|
2018
Q1 | $608K | Buy |
22,271
+1,892
| +9% | +$51.7K | 0.05% | 259 |
|
|
2017
Q4 | $505K | Sell |
20,379
-954
| -4% | -$23.6K | 0.04% | 278 |
|
|
2017
Q3 | $622K | Buy |
21,333
+10,843
| +103% | +$316K | 0.05% | 244 |
|
|
2017
Q2 | $291K | Hold |
10,490
| – | – | 0.02% | 322 |
|
|
2017
Q1 | $261K | Sell |
10,490
-60
| -0.6% | -$1.49K | 0.02% | 308 |
|
|
2016
Q4 | $228K | Sell |
10,550
-3,431
| -25% | -$74.1K | 0.02% | 309 |
|
|
2016
Q3 | $333K | Sell |
13,981
-9,979
| -42% | -$238K | 0.03% | 284 |
|
|
2016
Q2 | $560K | Sell |
23,960
-12,745
| -35% | -$298K | 0.05% | 253 |
|
|
2016
Q1 | $690K | Sell |
36,705
-76,059
| -67% | -$1.43M | 0.06% | 248 |
|
|
2015
Q4 | $2.08M | Sell |
112,764
-68,269
| -38% | -$1.26M | 0.17% | 156 |
|
|
2015
Q3 | $2.97M | Sell |
181,033
-2,350
| -1% | -$38.6K | 0.25% | 127 |
|
|
2015
Q2 | $3.25M | Buy |
+183,383
| New | +$3.25M | 0.25% | 127 |
|